1. Home
  2. BLCO vs ENIC Comparison

BLCO vs ENIC Comparison

Compare BLCO & ENIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • ENIC
  • Stock Information
  • Founded
  • BLCO 1853
  • ENIC 2016
  • Country
  • BLCO Canada
  • ENIC Chile
  • Employees
  • BLCO N/A
  • ENIC N/A
  • Industry
  • BLCO Ophthalmic Goods
  • ENIC Electric Utilities: Central
  • Sector
  • BLCO Health Care
  • ENIC Utilities
  • Exchange
  • BLCO Nasdaq
  • ENIC Nasdaq
  • Market Cap
  • BLCO 4.9B
  • ENIC 4.4B
  • IPO Year
  • BLCO 2022
  • ENIC N/A
  • Fundamental
  • Price
  • BLCO $15.01
  • ENIC $3.70
  • Analyst Decision
  • BLCO Hold
  • ENIC Hold
  • Analyst Count
  • BLCO 11
  • ENIC 2
  • Target Price
  • BLCO $15.80
  • ENIC $3.90
  • AVG Volume (30 Days)
  • BLCO 483.2K
  • ENIC 427.6K
  • Earning Date
  • BLCO 10-29-2025
  • ENIC 10-28-2025
  • Dividend Yield
  • BLCO N/A
  • ENIC 5.08%
  • EPS Growth
  • BLCO N/A
  • ENIC N/A
  • EPS
  • BLCO N/A
  • ENIC 0.00
  • Revenue
  • BLCO $4,891,000,000.00
  • ENIC $4,040,237,917.00
  • Revenue This Year
  • BLCO $8.27
  • ENIC $111,648.61
  • Revenue Next Year
  • BLCO $5.73
  • ENIC N/A
  • P/E Ratio
  • BLCO N/A
  • ENIC $37.47
  • Revenue Growth
  • BLCO 8.81
  • ENIC N/A
  • 52 Week Low
  • BLCO $10.45
  • ENIC $2.51
  • 52 Week High
  • BLCO $21.69
  • ENIC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 62.34
  • ENIC 73.97
  • Support Level
  • BLCO $14.53
  • ENIC $3.44
  • Resistance Level
  • BLCO $15.08
  • ENIC $3.63
  • Average True Range (ATR)
  • BLCO 0.33
  • ENIC 0.07
  • MACD
  • BLCO 0.00
  • ENIC 0.03
  • Stochastic Oscillator
  • BLCO 92.22
  • ENIC 97.23

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About ENIC Enel Chile S.A. (Each representing 50 shares of)

Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.

Share on Social Networks: